TrialEdge AI is an AI-native clinical development platform designed to accelerate clinical and regulatory processes in the life sciences sector. By leveraging intelligent automation, it reduces timelines, cuts costs, and enhances data quality, enabling life-saving treatments to reach patients more swiftly.
Key Features and Functionality:
- AI Protocol Assistant: Generates and optimizes study protocols with AI recommendations based on historical trial data.
- Smart eCRF Builder: Automatically creates electronic case report forms from protocols, incorporating built-in edit checks.
- Risk-Based Monitoring: Continuously monitors data quality, flagging anomalies before they escalate into costly issues.
- Multi-Region Support: Offers built-in localization, multi-language forms, and region-specific regulatory templates.
- Integration Capabilities: Seamlessly connects with EDC, CTMS, eTMF, lab, imaging, safety, and wearable systems through prebuilt integrations and open APIs.
- Pre-Submission Review: AI reviews study documents and datasets to identify inconsistencies, gaps, and compliance risks prior to submission, reducing costly review cycles.
Primary Value and User Solutions:
TrialEdge AI addresses the increasing complexity and cost of clinical trials by providing tools that streamline study design, execution, and submission processes. Its AI-driven approach ensures faster study builds, fewer protocol amendments, and lower operational costs. By integrating advanced machine learning and natural language processing, the platform enhances data quality and compliance, ultimately accelerating the delivery of new therapies to patients.
